Latest article
January 13, 2022
OP2101 - OrchestratePharma initiates phase 1 bioavailability study together with IVRS
Indian-based CRO company Invitro Research Solutions Ltd (IVRS) has been signed to take OP2101 to the first clinical step.
Read More
Indian-based CRO company Invitro Research Solutions Ltd (IVRS) has been signed to take OP2101 to the first clinical step.
Read More
OrchestratePharma GmbH signs agreement with DRPx drug discovery company Cellix Bioscience Pte Ltd
Read MoreAre you a patient, doctor, inventor or investor?
Follow us or join us on the journey.
Subscribe to our newsletter.
